Citations (16)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Dariusz Onichimowski, Krzysztof Nosek, Radosław Goraj, Rakesh Jalali, Aleksandra Wińska, Aleksandra Pawlos & Bułat Tuyakov. (2018) Use of levosimendan in the treatment of cerebral vascular vasospasm: a case study. Drug Design, Development and Therapy 12, pages 1777-1783.
Read now
Read now
Articles from other publishers (15)
Bora Gürer. 2023. Handbook of Animal Models in Neurological Disorders. Handbook of Animal Models in Neurological Disorders
631
640
.
Abdurrahman Aycan, Ersoy Oksuz, Edip Gonullu, Tuncay Kume, Bekir Ergur, Mehmet Edip Akyol, Abdurrahim Tas & Fetullah Kuyumcu. (2022) A New Approach in the Treatment of Traumatic Brain Injury: The Effects of Levosimendan on Necrosis, Apoptosis, and Oxidative Stress. World Neurosurgery 168, pages e432-e441.
Crossref
Crossref
Vincent Cottenceau, Bastien Poutier, Florent Gariel, Noemie Sauvage, Laurent Petit, Cedric Carrie & Matthieu Biais. (2019) May levosimendan be safe and effective in refractory vasospasm despite adequate treatment with repeated angiography and milrinone infusion after subarachnoid haemorrhage?. Anaesthesia Critical Care & Pain Medicine 38:6, pages 665-667.
Crossref
Crossref
Ammar Al-Chalabi, Leo M. A. Heunks, Zoltán Papp & Piero Pollesello. (2019) Potential of the Cardiovascular Drug Levosimendan in the Management of Amyotrophic Lateral Sclerosis. Journal of Cardiovascular Pharmacology 74:5, pages 389-399.
Crossref
Crossref
Emre BİLGİN, Kadir OKTAY, Semih Kıvanç OLGUNER, Gökhan ÇAVUŞ, Vedat AÇIK, Ali ARSLAN & Metin TUNA. (2019) Endothelin-1 levels in serum and cerebrospinal fluid after vasospasm following spontaneous subarachnoid haemorrhageSpontan subaraknoid kanamayı takiben gelişen vazospazm sonrası serum ve serebrospinal sıvıda endotelin-1 düzeyleri. Cukurova Medical Journal 44:2, pages 334-340.
Crossref
Crossref
Dimitrios Farmakis, Julian Alvarez, Tuvia Ben Gal, Dulce Brito, Francesco Fedele, Candida Fonseca, Anthony C. Gordon, Israel Gotsman, Elena Grossini, Fabio Guarracino, Veli-Pekka Harjola, Yaron Hellman, Leo Heunks, Visnja Ivancan, Apostolos Karavidas, Matti Kivikko, Vladimir Lomivorotov, Dan Longrois, Josep Masip, Marco Metra, Andrea Morelli, Maria Nikolaou, Zoltán Papp, Alexander Parkhomenko, Gerhard Poelzl, Piero Pollesello, Hanne Berg Ravn, Steffen Rex, Hynek Riha, Sven-Erik Ricksten, Robert H.G. Schwinger, Bojan Vrtovec, M. Birhan Yilmaz, Marzenna Zielinska & John Parissis. (2016) Levosimendan beyond inotropy and acute heart failure: Evidence of pleiotropic effects on the heart and other organs: An expert panel position paper. International Journal of Cardiology 222, pages 303-312.
Crossref
Crossref
Giolanda Varvarousi, Theodoros Xanthos, Pavlina Sarafidou, Ellisavet Katsioula, Marianthi Georgiadou, Maria Eforakopoulou & Hlias Pavlou. (2016) Role of levosimendan in the management of subarachnoid hemorrhage. The American Journal of Emergency Medicine 34:2, pages 298-306.
Crossref
Crossref
Matti Kivikko, Mikko Kuoppamäki, Lauri Soinne, Stig Sundberg, Pasi Pohjanjousi, Juha Ellmen & Risto O. Roine. (2015) Oral Levosimendan Increases Cerebral Blood Flow Velocities in Patients with a History of Stroke or Transient Ischemic Attack: A Pilot Safety Study. Current Therapeutic Research 77, pages 46-51.
Crossref
Crossref
Yuichiro Kikkawa, Ryota Kurogi & Tomio Sasaki. (2014) The Single and Double Blood Injection Rabbit Subarachnoid Hemorrhage Model. Translational Stroke Research 6:1, pages 88-97.
Crossref
Crossref
John Papanikolaou, Vasiliki Tsolaki, Demosthenes Makris & Epaminondas Zakynthinos. (2014) Early levosimendan administration may improve outcome in patients with subarachnoid hemorrhage complicated by acute heart failure. International Journal of Cardiology 176:3, pages 1435-1437.
Crossref
Crossref
Giolanda Varvarousi, Antonia Stefaniotou, Dimitrios Varvaroussis, Filippia Aroni & Theodoros Xanthos. (2014) The role of Levosimendan in cardiopulmonary resuscitation. European Journal of Pharmacology 740, pages 596-602.
Crossref
Crossref
Poongundran Namachivayam, Joseph J. Smolich, Amy E. Shields, Sandra Rees, Lee Coleman, Steven B. Horton, Igor E. Konstantinov, Daniel J. Penny & Lara S. Shekerdemian. (2014) Impact of levosimendan on brain injury patterns in a lamb model of infant cardiopulmonary bypass. Pediatric Research 76:1, pages 64-71.
Crossref
Crossref
Marc Hein, Norbert Zoremba, Chistian Bleilevens, Christian Bruells, Rolf Rossaint & Anna B Roehl. (2013) Levosimendan limits reperfusion injury in a rat middle cerebral artery occlusion (MCAO) model. BMC Neurology 13:1.
Crossref
Crossref
Anna B Roehl, Norbert Zoremba, Markus Kipp, Johannes Schiefer, Andreas Goetzenich, Christian Bleilevens, Nikolaus Kuehn-Velten, Rene Tolba, Rolf Rossaint & Marc Hein. (2012) The effects of levosimendan on brain metabolism during initial recovery from global transient ischaemia/hypoxia. BMC Neurology 12:1.
Crossref
Crossref
A. Küçük, M. Yucel, N. Erkasap, M. Tosun, T. Koken, M. Ozkurt & S. Erkasap. (2012) The effects of PDE5 inhibitory drugs on renal ischemia/reperfusion injury in rats. Molecular Biology Reports 39:10, pages 9775-9782.
Crossref
Crossref